Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
221.00    -1.00 (-0.45%)
Bid:
221.00
Ask:
232.00
Spread: 11.00 (4.977%)
Market Cap: £116.68m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Form 8 (OPD) Microgen plc

11 Jun 2014 09:34

ABERFORTH PARTNERS LLP - Form 8 (OPD) Microgen plc

ABERFORTH PARTNERS LLP - Form 8 (OPD) Microgen plc

PR Newswire

London, June 11

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Identity of the person whose positions/ Aberforth Partners LLP, ondealings are being disclosed: behalf of discretionary clients. (b) Owner or controller of interests and shortpositions disclosed, if different from 1(a): The naming of nominee or vehicle companies isinsufficient (c) Name of offeror/offeree in relation to Microgen plcwhose relevant securities this form relates: Use a separate form for each offeror/offeree (d) If an exempt fund manager connected withan offeror/offeree, state this and specifyidentity of offeror/offeree: (e) Date position held/dealing undertaken: 26 May 2014 (f) Has the discloser previously disclosed, or Y/N - NOare they today disclosing, under the Code inrespect of any other party to this offer? If YES, specify which: 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE (a) Interests and short positions in the relevant securities of the offeror orofferee to which the disclosure relates following the dealing (if any) Class of relevant security: Ordinary Shares Interests Short positions Number % Number % (1) Relevant securities owned 15,777,814 21.18 0 0.0and/or controlled: (2) Derivatives (other thanoptions): (3) Options and agreements topurchase/sell: TOTAL: 15,777,814 21.18 0 0.0 Aberforth Partners LLP does not have discretion regarding voting decisions inrespect of 6,201,206 shares included in the total disclosed above All interests and all short positions should be disclosed. Details of any open derivative or option positions, or agreements to purchaseor sell relevant securities, should be given on a Supplemental Form 8 (OpenPositions). (b) Rights to subscribe for new securities (including directors' and otherexecutive options) Class of relevant security in N/Arelation to which subscription rightexists: Details, including nature of the N/Arights concerned and relevantpercentages: If there are positions or rights to subscribe to disclose in more than oneclass of relevant securities of the offeror or offeree named in 1(c), copytable 2(a) or (b) (as appropriate) for each additional class of relevantsecurity. 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (a) Purchases and sales Class of relevant Purchase/sale Number of Price per unit security securities N/A- OpeningDisclosure (b) Derivatives transactions (other than options) Class of Product Nature of dealing Number of Price per relevant description reference unit security e.g. opening/closing a securities e.g. CFD long/short position, increasing/reducing a long/short position N/A (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Class of Product Writing, Number of Exercise Type Expiry Optionrelevant description purchasing, securities price date moneysecurity e.g. call selling, to which per unit e.g. paid/ option varying option American, received etc. relates European per unit etc. N/A (ii) Exercising Class of relevant Product Number of Exercise price per security description securities unit e.g. call option N/A (d) Other dealings (including subscribing for new securities) Class of relevant Nature of dealing Details Price per unit security (if applicable) e.g. subscription, conversion N/A The currency of all prices and other monetary amounts should be stated. Where there have been dealings in more than one class of relevant securities ofthe offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (asappropriate) for each additional class of relevant security dealt in. 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement orunderstanding, formal or informal, relating to relevant securities which maybe an inducement to deal or refrain from dealing entered into by the personmaking the disclosure and any party to the offer or any person acting inconcert with a party to the offer: If there are no such agreements, arrangements or understandings, state "none" None (b) Agreements, arrangements or understandings relating to options orderivatives Details of any agreement, arrangement or understanding, formal or informal,between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevantsecurities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" None (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? Y/N NO Date of disclosure: 27 May 2014 (amended 11 June 2014) Contact name: David Holland, for Aberforth Partners LLP Telephone number: 0131 220 0733 Public disclosures under Rule 8 of the Code must be made to a RegulatoryInformation Service and must also be emailed to the Takeover Panel atmonitoring@disclosure.org.uk . The Panel's Market Surveillance Unit isavailable for consultation in relation to the Code's dealing disclosurerequirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

Date   Source Headline
31st Aug 20177:00 amRNSAcquisition of RevStream
18th Aug 20174:36 pmRNSHolding(s) in Company
11th Aug 201710:47 amRNSAward of Options
4th Aug 20179:50 amRNSHolding(s) in Company
25th Jul 20173:50 pmRNSHolding(s) in Company
24th Jul 20171:12 pmRNSHolding(s) in Company
24th Jul 20177:00 amRNSInterim Results
6th Jul 20177:00 amRNSTrading Update and Notice of Results
30th Jun 20172:11 pmRNSTotal Voting Rights
21st Jun 20173:06 pmRNSHolding(s) in Company
2nd Jun 20171:43 pmRNSTotal Voting Rights
1st Jun 20177:00 amRNSHolding(s) in Company
17th May 20177:00 amRNSDirector Declaration
17th May 20177:00 amRNSHolding(s) in Company
12th May 201712:08 pmRNSHolding(s) in Company
9th May 20177:00 amRNSHolding(s) in Company
24th Apr 201712:15 pmRNSResult of AGM
24th Apr 20177:00 amRNSAGM Trading update
11th Apr 20174:09 pmRNSHolding(s) in Company
3rd Apr 20177:00 amRNSBlock listing Interim Review
21st Mar 201712:51 pmRNSHolding(s) in Company
17th Mar 201711:22 amRNSHolding(s) in Company
16th Mar 20174:31 pmRNSDirector/PDMR Shareholding
14th Mar 20174:32 pmRNSHolding(s) in Company
9th Mar 20174:38 pmRNSHolding(s) in Company
8th Mar 20177:00 amRNSAudited Preliminary Results
28th Feb 20177:00 amRNSDirectorate Change
27th Feb 20177:00 amRNSAcquisition of Primacy Corporation
6th Feb 20173:39 pmRNSHolding(s) in Company
3rd Feb 20175:22 pmRNSHolding(s) in Company
1st Feb 20172:24 pmRNSTotal Voting Rights
25th Jan 20177:00 amRNSNotice of Results and Business Update
21st Dec 20163:51 pmRNSDirector/PDMR Shareholding
17th Nov 201610:50 amRNSBlock Listing Application
10th Oct 20169:37 amRNSBlock listing Interim Review
3rd Oct 20169:45 amRNSTotal Voting Rights
4th Aug 20167:00 amRNSDirector/PDMR Shareholding
29th Jul 201612:41 pmRNSHolding(s) in Company
29th Jul 201612:33 pmRNSHolding(s) in Company
25th Jul 20169:32 amRNSHolding(s) in Company
18th Jul 20167:00 amRNSInterim Results
13th Jul 20164:22 pmRNSHolding(s) in Company
6th Jul 20167:00 amRNSNotice of Results
7th Jun 20165:18 pmRNSHolding(s) in Company
27th May 20164:47 pmRNSHolding(s) in Company
27th May 201612:18 pmRNSTotal Voting Rights
27th May 20167:00 amRNSHolding(s) in Company
16th May 20167:00 amRNSACQUISITION OF INFOSCREEN (CYPRUS) LIMITED
4th May 20162:53 pmRNSCompletion of Fleet Disposal
25th Apr 20169:49 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.